Skip to main content

Creutzfeldt Jakob Disease

Volume 486: debated on Thursday 22 January 2009

To ask the Secretary of State for Health (1) what the estimated cost is of testing for vCJD all those considered potentially at risk of having contracted vCJD after using infected blood products under the NHS; and if he will make a statement; (247050)

(2) how many and what proportion of those considered to be potentially at risk of having contracted vCJD after using infected blood products under the NHS have been informed of their at risk status; and if he will make a statement;

(3) how many haemophiliacs are estimated to be potentially at risk of having contracted vCJD after using infected blood products under the NHS; and if he will make a statement;

(4) how many people are estimated to be potentially at risk of having contracted vCJD after using infected blood products under the NHS; and if he will make a statement.

There are between 4,000 and 5,000 people, mostly haemophiliacs, currently considered at risk of variant Creutzfeldt-Jakob Disease because of exposure or potential exposure via blood products. The haemophiliacs have been informed of their risk status by the haemophilia doctors managing their care, and the general practitioners of those who are not haemophiliacs have been informed of the need to advise their patients appropriately. The cost of testing this group, should suitable tests become available, has not been estimated.